Our humanization service delivers antibodies that are not only de-immunized but also maintain binding affinity for the target and are optimised for manufacturability.
We are experienced in producing antibodies in a wide range of formats including scFv, Fab, bispecific and many more.
Early assessment of antibody lead candidates for developability can save millions in COGs and reduce timelines during development.
Our Rational Affinity Maturation Platform (RAMP™) uses proprietary library design approaches and in silico selection methods to deliver matured antibody sequences in record timelines.
Engineering a path to the clinic
We harness all aspects of antibody engineering to overcome obstacles to the clinic. From Intelligent design of ideal formats to address a therapeutic area to interrogating the sequence and structure of a client’s molecule in minute detail. We utilize our extensive expertise in the nuances of antibody engineering to produce lead molecules with ideal drug-like profiles. Ultimately, with the end in mind.